Biothrax Market

Biothrax Market contains market size and forecasts of Biothrax (Anthrax Vaccine) in global, including the following market information:

• Global Biothrax (Anthrax Vaccine) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Biothrax (Anthrax Vaccine) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Biothrax (Anthrax Vaccine) companies in 2021 (%)

The global Biothrax (Anthrax Vaccine) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Live Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biothrax (Anthrax Vaccine) include Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biognesis-Bago and CAVAC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Biothrax (Anthrax Vaccine) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biothrax (Anthrax Vaccine) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biothrax (Anthrax Vaccine) Market Segment Percentages, by Type, 2021 (%)

• Live Vaccines
• Cell Free PA Vaccines

Global Biothrax (Anthrax Vaccine) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biothrax (Anthrax Vaccine) Market Segment Percentages, by Application, 2021 (%)

• Human Use
• Animal Use

Global Biothrax (Anthrax Vaccine) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biothrax (Anthrax Vaccine) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Biothrax (Anthrax Vaccine) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Biothrax (Anthrax Vaccine) revenues share in global market, 2021 (%)
• Key companies Biothrax (Anthrax Vaccine) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Biothrax (Anthrax Vaccine) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merial
• Merck
• Zoetis
• Bayer Sanidad Animal
• Colorado Serum
• PharmAthene
• Tiankang
• Biognesis-Bago
• CAVAC
• Rosenbusch
• Agrovet
• Vecol
• CVCRI
• IVPM
• Prondil
• CDV
• Indian Immunologicals
• Botswana Vaccine Institute
• Ceva Sant Animale
• Intervac
• JOVAC